Social Media Press Releases
RSSShowing Press Releases with Tag: Hsp90 inhibitor
10/23/2007
Infinity and MedImmune Announce Issuance of U.S. Patent for Proprietary Heat Shock Protein 90 Inhibitors
» read more9/17/2007
Infinity and MedImmune Receive Orphan Drug Designation for IPI-504 for Treatment of Gastroinstestinal Stromal Tumors
» read more5/31/2007
Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
» read more4/10/2007
Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
» read more2/14/2007
Infinity and MedImmune Initiate Phase I/II Clinical Trial of IPI-504 for Patients With Non-Small Cell Lung Cancer
» read more12/09/2006
MedImmune’s Advancing Cancer Pipeline to Be Highlighted at the American Society of Hematology’s Annual Meeting
» read more11/07/2006
Infinity and MedImmune Announce Promising Biological Activity of Anti-Hsp90 Compound in Phase I GIST Trial
» read more8/28/2006
